Form 13-F position report

HALOZYME THERAPEUTICS INC

Reported by DeepCurrents Investment Group LLC

HALO 1 08/15/28 CUSIP 40637HAF6 Manager CIK 0001754535

First reported at 31,626,000 shares this quarter.

New
% of reported 13F value 1.79% This manager · Q3 2026
Shares 31,626,000 Quarter-end amount reported
Reported value $62,523,214 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-09-30 16394125
2024-12-31 14881006
2025-03-31 13161748
2025-06-30 8843370
2025-09-30 0
2026-09-30 62523214

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for HALOZYME THERAPEUTICS INC held by DeepCurrents Investment Group LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 31,626,000 +31,626,000 (0.0%) 1.79% $62,523,214 2026-11-13
Q3 2025 Reduced 0 -7,750,000 (-100.0%) 0 $0 2025-11-14
Q2 2025 Reduced 7,750,000 -2,500,000 (-24.4%) 0.3% $8,843,370 2025-08-14
Q1 2025 Reduced 10,250,000 -3,500,000 (-25.5%) 0.4% $13,161,748 2025-05-15
Q4 2024 Unchanged 13,750,000 0 (0.0%) 0.47% $14,881,006 2025-02-14
Q3 2024 New 13,750,000 +13,750,000 (0.0%) 0.49% $16,394,125 2024-11-14

Who else reported the position

54 managers reported HALOZYME THERAPEUTICS INC for Q3 2026.

Managers reporting HALOZYME THERAPEUTICS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
CITADEL ADVISORS LLC Reduced 45,144,000 -20,872,000 < 0.01% $89,243,815 13 qtrs
DeepCurrents Investment Group LLC This report New 31,626,000 +31,626,000 1.79% $62,523,214 1 qtr
Point72 Asset Management L P Reduced 28,953,000 -12,398,000 0.06% $57,196,033 5 qtrs
TENOR CAPITAL MANAGEMENT Co L P Reduced 26,023,000 -11,804,000 0.64% $51,490,755 5 qtrs
MILLENNIUM MANAGEMENT LLC Unchanged 0 0 0.02% $49,258,356 12 qtrs
BOUSSARD & GAVAUDAN GESTION SAS Added 19,635 +17,535 3.04% $39,270,200 2 qtrs
Alberta Investment Management Corp Reduced 15,302,000 -19,698,000 0.17% $30,547,975 7 qtrs
FMR LLC Unchanged 0 0 < 0.01% $14,922,256 10 qtrs
Citigroup Inc Added 7,005,000 +6,242,000 < 0.01% $13,777,574 4 qtrs
ABSOLUTE INVESTMENT ADVISERS LLC Reduced 5,246,000 -8,754,000 0.95% $10,347,735 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
NOTE 1.000% 8/1

Voting authority reported

Sole
23,956,000
Shared
7,670,000
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.